BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28062717)

  • 21. 2015 SNMMI Highlights Lecture: Oncology, Part II.
    Mahmood U
    J Nucl Med; 2015 Dec; 56(12):9N-16N. PubMed ID: 26626870
    [No Abstract]   [Full Text] [Related]  

  • 22. SNMMI Leadership Update: Advancing Research and Discovery.
    Greenspan BS
    J Nucl Med; 2018 Mar; 59(3):14N. PubMed ID: 29497009
    [No Abstract]   [Full Text] [Related]  

  • 23. 2015 SNMMI Highlights Lecture: Oncology, Part I.
    Mahmood U
    J Nucl Med; 2015 Nov; 56(11):9N-16N. PubMed ID: 26526798
    [No Abstract]   [Full Text] [Related]  

  • 24. Society of Nuclear Medicine and Molecular Imaging Efforts Toward Standardization: From Procedure Standards to Appropriate Use Criteria.
    Donohoe K; Ahuja S
    Semin Nucl Med; 2019 Mar; 49(2):153-160. PubMed ID: 30819395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SNMMI Leadership Update: FDA Approval of Imaging Agents: An Exciting Investment in Nuclear Medicine.
    Schwarz SW
    J Nucl Med; 2017 Jan; 58(1):20N. PubMed ID: 28062714
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined use of peptide receptor radionuclide therapy and metronomic chemotherapy in neuroendocrine tumors: a possible choice driven by nuclear medicine molecular imaging.
    Minutoli F; Laudicella R; Burger IA; Baldari S
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3041-3042. PubMed ID: 33851244
    [No Abstract]   [Full Text] [Related]  

  • 27. Joint NCI/SNMMI Workshop on Targeted Radionuclide Therapy.
    J Nucl Med; 2013 May; 54(5):16N-7. PubMed ID: 23757490
    [No Abstract]   [Full Text] [Related]  

  • 28. SNMMI COR Submits Recommendations, White Paper on Compounded Sterile Radiopharmaceuticals to USP.
    J Nucl Med; 2017 Jan; 58(1):16N-17N. PubMed ID: 28062711
    [No Abstract]   [Full Text] [Related]  

  • 29. EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours-the consensus in a nutshell.
    Kunikowska J; Ambrosini V; Herrmann K
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1276-1277. PubMed ID: 33624150
    [No Abstract]   [Full Text] [Related]  

  • 30. SNMMI Leadership Update: Influx of New Ideas and Opportunities Collaboration Propels Growth.
    Dilsizian V
    J Nucl Med; 2019 Jul; 60(7):13N. PubMed ID: 31263084
    [No Abstract]   [Full Text] [Related]  

  • 31. The SNMMI and EANM practice guideline for small-bowel and colon transit 1.0.
    Maurer AH; Camilleri M; Donohoe K; Knight LC; Madsen JL; Mariani G; Parkman HP; Van Dolsen J
    J Nucl Med; 2013 Nov; 54(11):2004-13. PubMed ID: 24092937
    [No Abstract]   [Full Text] [Related]  

  • 32. Highlights lecture EANM 2016: "Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine".
    Aboagye EO; Kraeber-Bodéré F
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1559-1574. PubMed ID: 28597119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. History Corner: from the new SNMMI historian.
    Fahey F
    J Nucl Med; 2015 Apr; 56(4):11N. PubMed ID: 25834174
    [No Abstract]   [Full Text] [Related]  

  • 34. EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours.
    Van Weehaeghe D; Lapauw B; Fraioli F; Cecchin D; Verger A; Guedj E; Albert NL; Brendel M; Yakushev I; Barthel H; Traub-Weidinger T; Tolboom N; Giessen EV
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2367-2370. PubMed ID: 38687371
    [No Abstract]   [Full Text] [Related]  

  • 35. SNMMI industry forum created to work together on areas of promise.
    J Nucl Med; 2015 Mar; 56(3):13N. PubMed ID: 25733601
    [No Abstract]   [Full Text] [Related]  

  • 36. SNMMI/EANM guideline for guideline development 6.0.
    Delbeke D; Chiti A; Christian P; Darcourt J; Donohoe K; Flotats A; Krause BJ; Royal HD
    J Nucl Med Technol; 2012 Dec; 40(4):283-9. PubMed ID: 22743147
    [No Abstract]   [Full Text] [Related]  

  • 37. Examining the nuclear medicine advanced associate: past, present, and future-a white paper presented by members of the graduate stakeholders committee of the SNMMI technologist section.
    Owen MA; Gilmore CD; Henkin R; Baldwin J; Bires AM; Nelson KP; Wilkinson D; Holbrook S; Hubble W; Mann A; Sobey K; Wintering NA
    J Nucl Med Technol; 2014 Sep; 42(3):223-7. PubMed ID: 25125451
    [No Abstract]   [Full Text] [Related]  

  • 38. 2014 SNMMI highlights lecture: Oncology.
    Mahmood U
    J Nucl Med; 2014 Nov; 55(11):9N-24N. PubMed ID: 25368337
    [No Abstract]   [Full Text] [Related]  

  • 39. SNMMI comments on NRC part 35 and part 20 rules.
    J Nucl Med; 2015 Jan; 56(1):11N. PubMed ID: 25556225
    [No Abstract]   [Full Text] [Related]  

  • 40. Nuclear Medicine Technologists' Perception and Current Assessment of Quality: A Society of Nuclear Medicine and Molecular Imaging Technologist Section Survey.
    Mann A; Farrell MB; Williams J; Basso D
    J Nucl Med Technol; 2017 Jun; 45(2):67-74. PubMed ID: 28473461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.